Scholars@Duke
Renato Delascio Lopes

Renato Delascio Lopes

Professor of Medicine
Medicine, Cardiology
renato.lopes@duke.edu
Duke Box 3850, Durham, NC 27715
300 W. Morgan St., Durham, NC 27701

Overview

Atrial Fibrillation
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine

Current Appointments & Affiliations

Professor of Medicine · 2021 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2009 - Present Duke Clinical Research Institute, Institutes and Centers

In the News

Published November 16, 2023
Which Duke Scholars Made the Most Cited List?
Published March 18, 2019
When Less is More: Some Heart Patients Should Skip Aspirin as Part of Treatment
Published March 15, 2019
Your Treatment for Heart Disease May Not Be Backed by Good Science

View All News

Recent Publications

IVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions

Journal Article Jacc Cardiovascular Interventions · January 12, 2026 Background Intravascular imaging–guided percutaneous coronary intervention (PCI) reduces cardiovascular events compared with angiography-guided PCI alone. However, there is a paucity of data comparing these approaches in patients with complex coronary arte ... Full text Cite

Albiglutide and atrial fibrillation in patients with Type 2 diabetes and established cardiovascular disease: insights from the Harmony Outcomes trial.

Journal Article Eur J Prev Cardiol · January 6, 2026 AIMS: Atrial fibrillation and flutter (AF) are common in patients with Type 2 diabetes and are associated with worse outcomes. METHODS AND RESULTS: Harmony Outcomes was a multi-centre, event-driven, double-blind, placebo-controlled trial comparing the effe ... Full text Link to item Cite

Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: An Open-Label, Multicenter Randomized Clinical Trial.

Journal Article JAMA · January 6, 2026 IMPORTANCE: The efficacy and safety of guideline-recommended treatments for heart failure (HF) are uncertain in patients with Chagas disease. OBJECTIVE: To evaluate the efficacy and safety of the angiotensin receptor-neprilysin inhibitor sacubitril/valsart ... Full text Link to item Cite
View All Publications

Recent Grants

Protocol CS12_CEC

Clinical TrialPrincipal Investigator · Awarded by Ionis Pharmaceuticals Inc · 2025 - 2029

A PROGRAM OF THREE STUDIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical TrialPrincipal Investigator · Awarded by Parexel International LLC · 2021 - 2029

Priovant BREPO

Clinical TrialPrincipal Investigator · Awarded by Priovant Therapeutics, Inc · 2022 - 2027

View All Grants

Education, Training & Certifications

Duke University, School of Medicine · 2009 M.H.S.
Paulista Medical School, University of Sao Paulo (Brazil) · 2006 Ph.D.
University of Santo Amaro (Brazil) · 2001 M.D.